Merck Receives the EPA's 2017 Green Chemistry Challenge Award

Jun 20, 2017 10:50 AM ET
Multimedia with summary

The U.S. Environmental Protection Agency (EPA) has awarded Merck its Green Chemistry Challenge Award for innovative technologies and state-of-the-art approaches to sustainable processes for one of our investigational products. Merck and other Green Chemistry Challenge Award recipients were honored at a ceremony at the National Academy of Sciences in Washington, D.C.

What is “green chemistry?”

Green chemistry is the design of chemical products and processes that reduce or eliminate the generation of hazardous substances. The EPA Green Chemistry Challenge Awards Program recognizes individuals and organizations for successfully researching, developing and implementing outstanding green chemical technologies.

This isn’t the first time Merck has received a Green Chemistry Challenge Award. The company has received three others:

  • 2010 Greener Reaction Conditions Award
  • 2006 Greener Synthetic Pathways Award
  • 2005 Greener Synthetic Pathways Award

Read the EPA's full press release here.

Learn more about Merck's green and sustainable science initiatives here.


About Merck
For more than a century, Merck, a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola.

For more information, visit